Prevalence of mupirocin resistance in Staphylococcus pseudintermedius.
In the United States, veterinary use of mupirocin is primarily limited to the treatment of canine pyoderma caused by methicillin-resistant Staphylococcus pseudintermedius (MRSP). In this study, only 1 of 581 S. pseudintermedius isolates tested was resistant to mupirocin and carried the high-level mupirocin resistance gene, ileS2, on a plasmid.
Department of Veterinary Pathobiology, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, Texas, USA.
Stacey M
SM
Godbeer
Randi M
RM
Gold
Sara D
SD
Lawhon
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D004269:DNA, Bacterial / Q000737:chemistry / Q000235:genetics; D004285:Dogs; D024881:Drug Resistance, Bacterial; D005798:Genes, Bacterial; D008969:Molecular Sequence Data; D016712:Mupirocin / Q000494:pharmacology*; D016133:Polymerase Chain Reaction; D015995:Prevalence; D011711:Pyoderma / Q000382:microbiology / Q000662:veterinary; D017422:Sequence Analysis, DNA; D013203:Staphylococcal Infections / Q000382:microbiology / Q000662:veterinary; D013210:Staphylococcus / Q000187:drug effects* / Q000235:genetics / Q000302:isolation & purification; D014481:United States
D000900:Anti-Bacterial Agents; D004269:DNA, Bacterial; D016712:Mupirocin